Oral iron chelating drugs: coming but not yet ready for clinical use

This publication has 13 references indexed in Scilit:

• 1,2-DIMETHYL-3-HYDROXYPYRID-4-ONE, AN ORALLY ACTIVE CHELATOR FOR TREATMENT OF IRON OVERLOAD
  The Lancet, 1987
• Orally active α-ketohydroxy pyridine iron chelators intended for clinical use: in vivo studies in rabbits
  British Journal of Haematology, 1986
• Prevention of Cardiac Disease by Subcutaneous Deferoxamine in Patients with Thalassemia Major
  New England Journal of Medicine, 1985
• Oxygen toxicity, oxygen radicals, transition metals and disease
  Biochemical Journal, 1984
• DESFERRIOXAMINE TO IMPROVE CARDIAC FUNCTION IN IRON-OVERLOADED PATIENTS WITH THALASSAEMIA MAJOR
  The Lancet, 1984
• Pyridoxal complexes as potential chelating agents for oral therapy in transfusional iron overload
  Journal of Pharmacy and Pharmacology, 1982
• Survival and desferrioxamine in thalassaemia major.
  BMJ, 1982
• A study of intracellular iron metabolism using pyridoxal isonicotinoyl hydrazone and other synthetic chelating agents
  Biochimica et Biophysica Acta (BBA) - General Subjects, 1979
• Long-term Chelation Therapy in Thalassaemia Major: Effect on Liver Iron Concentration, Liver Histology, and Clinical Progress
  BMJ, 1974
• Cardiac Involvement in Cooley's Anemia
  Annals of the New York Academy of Sciences, 1964